Literature DB >> 18085037

Prevalence of chronic obstructive pulmonary disease among smokers aged 45 and up in Israel.

David Stav1, Meir Raz.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease is an increasing cause of chronic morbidity and mortality around the world. The major cause of the disease is smoking. Despite the gravity of the problem there is no knowledge of its rate in the Israeli smoking population.
OBJECTIVES: To assess the prevalence of COPD and early lung cancer among smokers.
METHODS: People aged 45 up to 75 with a history of at least 20 pack-years cigarette smoking, including quitters, were screened for COPD. They were interviewed and a spirometry was performed.
RESULTS: Of the 1150 people recruited 92% underwent and performed acceptable spirometry; 22% of these subjects had airflow limitation and were diagnosed with COPD according to the GOLD classification. Only 4% had been diagnosed as COPD prior to this screening. The majority of those tested were unaware of or unconcerned about developing the disease. There was no correlation between pack-years smoking and development of COPD, but there was a relative correlation of pack-years smoking and severity of COPD, particularly in the older group (r = 0.42).
CONCLUSIONS: About one-fifth of the smokers aged 45 and up developed COPD. There is a significant gap between the disease distribution and its awareness in the population at risk. The need for a national screening program and early diagnosis of COPD in people at risk is needed.

Entities:  

Mesh:

Year:  2007        PMID: 18085037

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  10 in total

1.  Chronic obstructive pulmonary disease among lung cancer-free smokers: The importance of healthy controls.

Authors:  Michelle D Karpman; Ronald Eldridge; Jack L Follis; Carol J Etzel; Sanjay Shete; Randa A El-Zein
Journal:  Respir Investig       Date:  2017-12-06

2.  Early Detection of COPD: An Opportunistic Case Finding Study in Smokers and Ex-Smokers Visiting a Medical Centre.

Authors:  Ariel Rokach; Abraham Bohadana; Ofir Kotek; Chen-Chen Shuali; Hava Azulai; Polina Babai; Yossi Freier-Dror; Gabriel Izbicki
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-06-01

3.  Individual and cumulative effects of GWAS susceptibility loci in lung cancer: associations after sub-phenotyping for COPD.

Authors:  Robert P Young; Raewyn J Hopkins; Chris F Whittington; Bryan A Hay; Michael J Epton; Gregory D Gamble
Journal:  PLoS One       Date:  2011-02-03       Impact factor: 3.240

4.  Geographical distribution of COPD prevalence in Europe, estimated by an inverse distance weighting interpolation technique.

Authors:  Ignacio Blanco; Isidro Diego; Patricia Bueno; Eloy Fernández; Francisco Casas-Maldonado; Cristina Esquinas; Joan B Soriano; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-12-21

5.  Method for evaluating multiple mediators: mediating effects of smoking and COPD on the association between the CHRNA5-A3 variant and lung cancer risk.

Authors:  Jian Wang; Margaret R Spitz; Christopher I Amos; Xifeng Wu; David W Wetter; Paul M Cinciripini; Sanjay Shete
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

6.  FAM13A locus in COPD is independently associated with lung cancer - evidence of a molecular genetic link between COPD and lung cancer.

Authors:  Robert P Young; Raewyn J Hopkins; Bryan A Hay; Chris F Whittington; Michael J Epton; Gregory D Gamble
Journal:  Appl Clin Genet       Date:  2010-12-22

7.  Genetic evidence linking lung cancer and COPD: a new perspective.

Authors:  Robert P Young; Raewyn J Hopkins; Gregory D Gamble; Carol Etzel; Randa El-Zein; James D Crapo
Journal:  Appl Clin Genet       Date:  2011-07-18

8.  GSTM1 null genotype in COPD and lung cancer: evidence of a modifier or confounding effect?

Authors:  Robert P Young; Raewyn J Hopkins; Bryan A Hay; Gregory D Gamble
Journal:  Appl Clin Genet       Date:  2011-09-13

Review 9.  Global and regional estimates of COPD prevalence: Systematic review and meta-analysis.

Authors:  Davies Adeloye; Stephen Chua; Chinwei Lee; Catriona Basquill; Angeliki Papana; Evropi Theodoratou; Harish Nair; Danijela Gasevic; Devi Sridhar; Harry Campbell; Kit Yee Chan; Aziz Sheikh; Igor Rudan
Journal:  J Glob Health       Date:  2015-12       Impact factor: 7.664

10.  The importance of having good quality indicators for care of patients with COPD: a look at hospital readmission rates.

Authors:  Michal Shani; Doron Comaneshter; Michael J Segel
Journal:  Isr J Health Policy Res       Date:  2022-03-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.